BeiGene, Ltd. (ONC) — Quality & forensics
As of 2026-10-12 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 30
- Quality 62
- Growth 87
- Balance sheet 80
- Cash quality 82
- Capital allocation 11
- Momentum 76
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the ONC chart & overview · the earnings record
FAQ · from the current data · as of 2026-10-12
Quick answers
What is BeiGene, Ltd.'s Closelooknet quality reading?
The composite reads 63/100 across 7 modules, as of 2026-10-12: valuation 30, quality 62, growth 87, balance sheet 80, cash quality 82, capital allocation 11, momentum 76. Closelooknet scores are research diary readings, not ratings or investment advice.
What is BeiGene, Ltd.'s Altman Z-Score?
6.53, which sits in the safe zone (above 2.99) as of 2026-10-12. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is BeiGene, Ltd.'s Piotroski F-Score?
7 of 9, as of 2026-10-12. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does BeiGene, Ltd.'s Beneish M-Score indicate?
-2.64 — below the −1.78 manipulation-risk threshold, as of 2026-10-12. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- KRYS Krystal Biotech Incindustry
- PTGX Protagonist Therapeutics Incindustry
- REGN Regeneron Pharmaceuticals Incindustry
- MRNA Moderna Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- CAI Caris Life Sciences, Inc. Common Stockindustry
- RXRX Recursion Pharmaceuticals Incindustry
- EXEL Exelixis Incindustry
- TWST Twist Bioscience Corpindustry
- TECH Bio-Techne Corpindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- RPRX Royalty Pharma Plcindustry
- BION.SW BB Biotech AGindustry
- INCY Incyte Corporationindustry
- JAZZ Jazz Pharmaceuticals PLCindustry
- NTLA Intellia Therapeutics Incindustry